GlassScriptPhysician profile
Albert C Evans
NPI 1346220605
$1,915.00
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $327 · 2021: $771 · 2022: $490.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $497.30 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $365.46 | 2019-2021 | |
| Alcon Vision LLC | $339.97 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $125.76 | 2021 | |
| Abbvie INC. | $124.97 | 2022 | |
| Dompe US, INC. | $121.45 | 2021 | |
| Ocular Therapeutix, INC. | $91.51 | 2022 | |
| Optovue, INC. | $88.06 | 2021 | |
| Coopervision INC. | $82.67 | 2021 | |
| Glaukos Corporation | $77.85 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.